SIGLEC1 and rheumatoid arthritis: In a study on patients with inflammatory arthralgia, naïve to any treatment, the authors demonstrated that patients who would develop RA had a specific IFN signature, with an up-regulation of SIGLEC1 and MS4A4A, differently from patients who presented with non-inflammatory arthralgia (30).